Andrew Hessel is the CEO of Humane Genomics Inc., a seed-stage company developing virus-based therapies for cancer, starting with dogs and also co-founded the Genome Project-write, an international scientific effort working to engineer large genomes, including the human genome.
Andy has been Singularity University faculty since 2009 and from 2012-2017 was the Distinguished Researcher at Autodesk Life Sciences.
Andy’s goal is to help people better understand and use living systems to meet the needs of society and he has written articles on genetic technology for The Atlantic, Wired UK, and Huffington Post and given over 100 invited talks on next-generation biotechnology.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | RSS | FREE BONUSES